Home › Funds › Hunting Hill Global Capital, LLC › RPRX

Hunting Hill Global Capital, LLC position in RPRX

ROYALTY PHARMA PLC · Health Care

Hunting Hill Global Capital, LLC reported holding 6,036 shares of RPRX (ROYALTY PHARMA PLC) in its Q1 2026 13F filing — a position valued at US$290K, representing 0.31% of its reported portfolio and ranking #45 among its reported holdings. Hunting Hill Global Capital, LLC has disclosed RPRX holdings in 9 of the last 9 reported quarters, going back to Q1 2024.

Latest position (Q1 2026)6.04K sh
Reported value held$289.55K
Portfolio Weight0.31%
First reportedQ1 2024
Last changeReduce
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How Hunting Hill Global Capital, LLC's RPRX position evolved

Hunting Hill Global Capital, LLC first disclosed a stake in RPRX in Q1 2024 at 15,934 shares (US$484K). The position peaked in Q2 2025 at 15,934 shares, worth US$574K. Across 9 filings, Hunting Hill Global Capital, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 6 time(s). The most recent filing (Q1 2026) shows 6,036 shares valued at US$290K — a reduction of -6,604 shares quarter over quarter.. Notable position changes include a 52% trim in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 15.93K $483.92K New
Q2 2024 15.93K $420.18K Hold
Q3 2024 15.93K $450.77K Hold
Q4 2024 15.93K $406.48K Hold
Q1 2025 15.93K $496.02K Hold
Q2 2025 15.93K $574.10K Hold
Q3 2025 15.93K $562.15K Hold
Q4 2025 12.64K $488.41K Reduce
Q1 2026 6.04K $289.55K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RPRX and 13F data

RPRX (ROYALTY PHARMA PLC) is a Health Care company. 50 other funds we track also report a position in RPRX — the largest reported positions include Swedbank AB (US$601.4M), Baillie Gifford & Co (US$561.6M), Caledonia (Private) Investments Pty Ltd (US$323.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RPRX

All RPRX fund holders →

FAQ

How long has Hunting Hill Global Capital, LLC held RPRX?

Hunting Hill Global Capital, LLC has disclosed RPRX holdings in 9 of the last 9 reported quarters, going back to Q1 2024.

What is Hunting Hill Global Capital, LLC's current position in RPRX?

As of Q1 2026, Hunting Hill Global Capital, LLC holds 6.04K shares of RPRX (ROYALTY PHARMA PLC), valued at $289.55K, representing 0.31% of its reported portfolio and ranking #45.

Has Hunting Hill Global Capital, LLC been buying or selling RPRX?

In the latest 13F filing (Q1 2026), Hunting Hill Global Capital, LLC reduced its position in RPRX. The position peaked in Q2 2025 at 15.93K shares.

Which other funds hold RPRX?

Other major institutional holders of RPRX include Swedbank AB, Baillie Gifford & Co, Caledonia (Private) Investments Pty Ltd, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.